drugset / Trial / NCT03795519
A Trial to Study the Absorption, Metabolism, and Excretion of [14C]-Olinciguat in Healthy Male Volunteers
NaSingle-groupOpen-labelOther
Summary
The primary objective is to characterize the pharmacokinetics (PK) of olinciguat and total radioactivity and to assess the elimination of total radioactivity from a single oral dose of \[14C\]-olinciguat.
Timeline
- Start
- 2019-01-17
- Primary completion
- 2019-02-27
- Completion
- 2019-02-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Olinciguat | Small molecule | — | Oral |
Indications
No indication recorded.